keyword
Keywords Bone Marrow Concentrate and Os...

Bone Marrow Concentrate and Osteoarthritis

https://read.qxmd.com/read/37321293/non-operative-management-of-shoulder-osteoarthritis-current-concepts
#21
JOURNAL ARTICLE
Nobuyuki Yamamoto, Dominik Szymski, Andreas Voss, Hiroaki Ishikawa, Takayuki Muraki, Ronaldo A Cunha, Benno Ejnisman, Joseph Noack, Eric McCarty, Mary K Mulcahey, Eiji Itoi
Glenohumeral osteoarthritis (OA) is one of the most common causes of shoulder pain. Conservative treatment options include physical therapy, pharmacological therapy, and biological therapy. Patients with glenohumeral OA present shoulder pain and decreased shoulder range of motion (ROM). Abnormal scapular motion is also seen in patients as adaptation to the restricted glenohumeral motion. Physical therapy is performed to (1) decrease pain, (2) increase shoulder ROM, and (3) protect the glenohumeral joint. To decrease pain, it should be assessed whether the pain appears at rest or during shoulder motion...
October 2023: Journal of ISAKOS
https://read.qxmd.com/read/37211834/derivation-of-a-clinical-decision-rule-for-a-bone-marrow-aspirate-concentrate-injection-in-knee-osteoarthritis
#22
JOURNAL ARTICLE
Ashley D Smith, Dasan Sydora, Robert Burnham
Aim: To develop a simple clinical decision rule (CDR) to identify people with knee osteoarthritis who are likely or unlikely to benefit from bone marrow aspirate concentrate (BMAC) injection. Materials & methods: A total of 92 people with clinical and radiographic evidence of refractory knee osteoarthritis received a single intra-articular (IA) BMAC injection. Multiple logistic regression analysis was used to determine which combination of risk factors predicted BMAC responsiveness. A responder was defined as a person whose knee pain improved more than 15% from baseline 6 months post procedure...
June 2023: Regenerative Medicine
https://read.qxmd.com/read/37170296/intra-articular-injection-of-bone-marrow-aspirate-concentrate-bmac-or-adipose-derived-stem-cells-adscs-for-knee-osteoarthritis-a-prospective-comparative-clinical-trial
#23
JOURNAL ARTICLE
Andrea Pintore, Donato Notarfrancesco, Arnaldo Zara, Antonio Oliviero, Filippo Migliorini, Francesco Oliva, Nicola Maffulli
BACKGROUND: We determined whether autologous mesenchymal stem cells (MSCs) injections provide clinical and functional improvements in knee osteoarthritis (KOA) patients, and whether the results differ between autologous bone marrow cells (BMAC) and adipose-derived stromal cells (ADSCs). METHODS: Between January 2021 and April 2022, 51 patients undergoing intra-articular injection of BMAC and 51 patients undergoing intra-articular injection of ADSCs were prospectively recruited...
May 11, 2023: Journal of Orthopaedic Surgery and Research
https://read.qxmd.com/read/37138690/computer-assisted-and-hip-arthroscopy-for-avascular-necrosis-of-the-femoral-head-with-femoroacetabular-impingement
#24
JOURNAL ARTICLE
Yu-Mei Wu, Yi-Lin Xiong, Wei-Jie Liu, Hang Tang, Yi-Fan Xiao, Shu-Guang Gao
Avascular necrosis of the femoral head with femoroacetabular impingement is a disabling disease. Without early treatment and intervention, its further development will even lead to hip osteoarthritis and hip dysfunction. This technical note aims to introduce a computer-assisted precise core decompression of the femoral head, followed by injection of platelet-rich plasma and bone marrow aspirate concentrate. Then, the autologous ipsilateral iliac bone is transplanted to the core decompression area. Thereafter, under hip arthroscopy, the injured glenoid lip of the hip joint is repaired, and the cam deformity of the femoral head/neck junction is polished and formed...
April 2023: Arthroscopy Techniques
https://read.qxmd.com/read/37071148/orthobiologics-a-review
#25
REVIEW
Andreas F Mavrogenis, Vasileios Karampikas, Alexandros Zikopoulos, Spyridon Sioutis, Dimitrios Mastrokalos, Dimitrios Koulalis, Marius M Scarlat, Philippe Hernigou
PURPOSE: The use of biologic materials in orthopaedics (orthobiologics) has gained significant attention over the past years. To enhance the body of the related literature, this review article is aimed at summarizing these novel biologic therapies in orthopaedics and at discussing their multiple clinical implementations and outcomes. METHODS: This review of the literature presents the methods, clinical applications, impact, cost-effectiveness, and outcomes, as well as the current indications and future perspectives of orthobiologics, namely, platelet-rich plasma, mesenchymal stem cells, bone marrow aspirate concentrate, growth factors, and tissue engineering...
July 2023: International Orthopaedics
https://read.qxmd.com/read/37026780/rethinking-cartilage-lesions-of-the-ankle-an-update-on-the-role-of-biologic-adjuvants
#26
JOURNAL ARTICLE
Arianna L Gianakos, John G Kennedy
Osteochondral lesions of the talus are common injuries in the ankle joint often resulting in early-onset osteoarthritis if left untreated. The avascular nature of articular cartilage limits healing capacity; therefore, surgical strategies are typically used in the treatment of these injuries. These treatments often result in the production of fibrocartilage rather than the native hyaline cartilage, which has decreased mechanical and tribological properties. Strategies to improve the ability of fibrocartilage to be more hyaline-like and thus more mechanically robust have been widely investigated...
July 15, 2023: Journal of the American Academy of Orthopaedic Surgeons
https://read.qxmd.com/read/36998601/mitochondrial-calcium-nanoregulators-reverse-the-macrophage-proinflammatory-phenotype-through-restoring-mitochondrial-calcium-homeostasis-for-the-treatment-of-osteoarthritis
#27
JOURNAL ARTICLE
Xiao Lei, Guodong Tan, Yiming Wang, Li Chen, Yuan Cao, Bingxin Si, Zhen Zhen, Bei Li, Yan Jin, Wei Wang, Fang Jin
INTRODUCTION: Osteoarthritis (OA) is a chronic degenerative joint disease accompanied by an elevated macrophage proinflammatory phenotype, which is triggered by persistent pathologically elevated calcium ion levels in mitochondria. However, existing pharmacological compounds targeting the inhibition of mitochondrial calcium ion (m[Ca2+ ]) influx are currently limited in terms of plasma membrane permeability and low specificity for ion channels and transporters. In the present study, we synthesized mesoporous silica nanoparticle-amidated (MSN)-ethylenebis (oxyethylenenitrilo)tetraacetic acid (EGTA)/triphenylphosphine (TPP)-polyethylene glycol (PEG) [METP] nanoparticles (NPs), which specifically target mitochondria and block excess calcium ion influx...
2023: International Journal of Nanomedicine
https://read.qxmd.com/read/36984635/bone-marrow-aspirate-concentrate-versus-human-umbilical-cord-blood-derived-mesenchymal-stem-cells-for-combined-cartilage-regeneration-procedure-in-patients-undergoing-high-tibial-osteotomy-a-systematic-review-and-meta-analysis
#28
JOURNAL ARTICLE
Dojoon Park, Youn Ho Choi, Se Hyun Kang, Hae Seok Koh, Yong In
Background and objectives: Cartilage regeneration using mesenchymal stem cells (MSCs) has been attempted to improve articular cartilage regeneration in varus knee osteoarthritis (OA) patients undergoing high tibial osteotomy (HTO). Bone marrow aspirate concentrate (BMAC) and human umbilical cord blood-derived MSCs (hUCB-MSCs) have been reported to be effective. However, whether BMAC is superior to hUCB-MSCs remains unclear. This systematic review and meta-analysis aimed to determine the clinical efficacy of cartilage repair procedures with BMAC or hUCB-MSCs in patients undergoing HTO...
March 22, 2023: Medicina
https://read.qxmd.com/read/36941604/using-multivariate-nonlinear-mixed-effects-model-to-investigate-factors-influencing-symptom-improvement-after-high-tibial-osteotomy-in-combination-with-bone-marrow-concentrate-injection-for-medial-compartment-knee-osteoarthritis-a-prospective-open-label-study
#29
JOURNAL ARTICLE
Hsiao-Yi Cheng, Chun-Wei Liang, Chen-Lun Chu, Hao-Wei Hsu, Sheng-Mou Hou, Kao-Shang Shih
PURPOSE: To investigate the effects of various demographic, structural, radiographic, and clinical factors on the prognosis of patients with medial compartmental knee osteoarthritis with varus deformity undergoing medial opening wedge high tibial osteotomy (HTO) in combination with bone marrow concentrate (BMC) injection. METHODS: In this prospective study, 20 patients underwent medial opening wedge HTO in combination with BMC injection with 12 months of follow-up...
March 20, 2023: BMC Musculoskeletal Disorders
https://read.qxmd.com/read/36928478/quantitative-bone-marrow-lesion-meniscus-and-synovitis-measurement-current-status
#30
REVIEW
Stacy E Smith, Sara M Bahouth, Jeffrey Duryea
Imaging plays a pivotal role in osteoarthritis research, particularly in epidemiological and clinical trials of knee osteoarthritis (KOA), with the ultimate goal being the development of an effective drug treatment for future prevention or cessation of disease. Imaging assessment methods can be semi-quantitative, quantitative, or a combination, with quantitative methods usually relying on software to assist. The software generally attempts image segmentation (outlining of relevant structures). New techniques using artificial intelligence (AI) or deep learning (DL) are currently a frequent topic of research...
March 16, 2023: Skeletal Radiology
https://read.qxmd.com/read/36913992/patients-with-knee-osteoarthritis-who-receive-platelet-rich-plasma-or-bone-marrow-aspirate-concentrate-injections-have-better-outcomes-than-patients-who-receive-hyaluronic-acid-systematic-review-and-meta-analysis
#31
REVIEW
John W Belk, Joseph J Lim, Carson Keeter, Patrick C McCulloch, Darby A Houck, Eric C McCarty, Rachel M Frank, Matthew J Kraeutler
PURPOSE: To systematically review the literature to compare the efficacy and safety of platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and hyaluronic acid (HA) injections for the treatment of knee osteoarthritis (OA). METHODS: A systematic review was performed by searching PubMed, the Cochrane Library, and Embase to identify Level I studies that compared the clinical efficacy of at least 2 of the following 3 injection therapies: PRP, BMAC, and HA for knee OA...
July 2023: Arthroscopy
https://read.qxmd.com/read/36873113/autologous-hematopoietic-bone-marrow-and-concentrated-growth-factor-transplantation-combined-with-core-decompression-in-patients-with-avascular-necrosis-of-the-femoral-head
#32
JOURNAL ARTICLE
Nasser Ghaly Yousif, Adnan Essa Kadhum Al Kilabi, Karrar Kareem Hatem, Hamdullah Hadi Al-Albaseesee, Wejdi Abbass Yassin Al-Fatlawy, Majid Alhamadani, Ulrich Aran Nöth, Ahmed Altmimi
The study aimed to assess the effectiveness of autologous hematopoietic bone marrow and concentrated growth factor (CGF) transplantation and core decompression in patients with avascular necrosis of the femoral head (ANFH). We performed a single-center prospective study on 31 patients with non-traumatic early-stage (stage I to III) ANFH based on the 1994 classification of the Association Research Circulation Osseous (ARCO). The patients were subjected to bone marrow aspiration from the posterior iliac crest, separation, and concentration of growth factors from the bone marrow aspirate, core decompression of the femoral head, and injection of hematopoietic bone marrow and CGFs into the necrotic lesion...
January 2023: Journal of Medicine and Life
https://read.qxmd.com/read/36798799/the-use-of-biologics-in-nfl-athletes-an-expert-consensus-of-nfl-team-physicians
#33
JOURNAL ARTICLE
Iain R Murray, Timothy R McAdams, Kyle E Hammond, Fares S Haddad, Scott A Rodeo, Geoffrey D Abrams, Larry Bankston, Asheesh Bedi, Martin Boublik, Mark Bowen, James P Bradley, Dan E Cooper, Charles Craythorne, Leigh-Ann Curl, Neal ElAttrache, David S Gazzaniga, Kevin Kaplan, Elias Edward Khalfayan, Christopher Larson, Matthew Pepe, Mark D Price, J Paul Schroeppel, James Voos, Gary Waslewski, Robin West
BACKGROUND: There is a lack of published information outlining the use of biologics in National Football League (NFL) athletes and limited data to guide biologic treatment strategies. PURPOSE: To develop a consensus on the use of biologics among NFL team physicians. STUDY DESIGN: Consensus statement. METHODS: A working group of 6 experts convened a consensus process involving NFL team physicians using validated Delphi methodology...
February 2023: Orthopaedic Journal of Sports Medicine
https://read.qxmd.com/read/36561706/use-of-bone-marrow-derived-mesenchymal-stem-cells-for-the-treatment-of-osteoarthritis-a-retrospective-long-term-follow-up-study
#34
JOURNAL ARTICLE
Cesare Mariani, Ezio Meneghetti, Doriano Zambon, Nicholas Elena, Alberto Agueci, Claudio Melchior
BACKGROUND: Available studies suggest that bone marrow concentrate, highly enriched in mesenchymal stem cells, is a potentially encouraging treatment for knee osteoarthritis. The aim of this retrospective study was to evaluate the clinical outcome in patients affected by this condition after treatment with autologous bone marrow aspirate concentrate (BMAC). METHODS: 55 patients who had undergone a single intra-articular injection of BMAC were administered two questionnaires to clinically evaluate their condition based on patient-reported outcome measures before treatment and at follow-up...
January 2023: Journal of Clinical Orthopaedics and Trauma
https://read.qxmd.com/read/36557003/cartilage-regeneration-using-human-umbilical-cord-blood-derived-mesenchymal-stem-cells-a-systematic-review-and-meta-analysis
#35
REVIEW
Dong Hwan Lee, Seon Ae Kim, Jun-Seob Song, Asode Ananthram Shetty, Bo-Hyoung Kim, Seok Jung Kim
Background and Objectives: Human umbilical-cord-blood-derived mesenchymal stem cells (hUCB-MSCs) have recently been used in clinical cartilage regeneration procedures with the expectation of improved regeneration capacity. However, the number of studies using hUCB-MSCs is still insufficient, and long-term follow-up results after use are insufficient, indicating the need for additional data and research. We have attempted to prove the efficacy and safety of hUCB-MSC treatment in a comprehensive analysis by including all subjects with knee articular cartilage defect or osteoarthritis who have undergone cartilage repair surgery using hUCB-MSCs...
December 6, 2022: Medicina
https://read.qxmd.com/read/36473210/aaos-technology-overview-summary-concentrated-bone-marrow-aspirate-for-knee-osteoarthritis
#36
JOURNAL ARTICLE
Arun Aneja, Samuel B Adams, Jeffrey A Foster, Ryan Pezold
The Concentrated Bone Marrow Aspirate (CBMA) for Knee Osteoarthritis Technology Overview is based on a systematic review of current scientific and clinical research. Through analysis of the current best evidence, this technology overview seeks to evaluate the efficacy of CBMA for patients with knee osteoarthritis. The systematic literature review resulted in 12 articles: three high-quality, four moderate-quality, and five low-quality. The findings of these studies were summarized to present findings on CBMA versus placebo and CBMA versus other treatment modalities...
December 5, 2022: Journal of the American Academy of Orthopaedic Surgeons
https://read.qxmd.com/read/36468635/prospective-double-blind-randomised-controlled-trial-protocol-comparing-bone-marrow-aspirate-concentrate-intra-articular-injection-combined-with-subchondral-injection-versus-intra-articular-injection-alone-for-the-treatment-of-symptomatic-knee-osteoarthritis
#37
JOURNAL ARTICLE
Simone Silva, Luca Andriolo, Angelo Boffa, Alessandro Di Martino, Davide Reale, Giulio Vara, Marco Miceli, Carola Cavallo, Brunella Grigolo, Stefano Zaffagnini, Giuseppe Filardo
INTRODUCTION: Subchondral and intra-articular injections of bone marrow aspirate concentrate (BMAC) showed promising results for knee osteoarthritis (OA) patients. To date, there is no evidence to demonstrate whether the combination of these treatments provides higher benefits than the intra-articular injection alone. METHODS AND ANALYSIS: Eighty-six patients with symptomatic knee OA (aged between 40 and 70 years) are randomised to BMAC intra-articular injection combined with subchondral BMAC injection or BMAC intra-articular injection alone in a ratio of 1:1...
September 8, 2022: BMJ Open
https://read.qxmd.com/read/36443838/intra-articular-injection-choice-for-osteoarthritis-making-sense-of-cell-source-an-updated-systematic-review-and-dual-network-meta-analysis
#38
REVIEW
Yijian Zhang, Huilin Yang, Fan He, Xuesong Zhu
BACKGROUND: Intra-articular injection is indicated for mild or moderate osteoarthritis (OA). However, the superiority of cell-based injection and the role of diverse cell sources are still unclear. This study aimed to compare the therapeutic effect of intra-articular injection with mesenchymal stem cells (MSCs) and cell-free methods for OA treatment. METHODS: A literature search of published scientific data was carried out from PubMed, MEDLINE, Embase, Cochrane Library, Web of Science, and China National Knowledge Internet (CNKI)...
November 28, 2022: Arthritis Research & Therapy
https://read.qxmd.com/read/36440184/short-term-efficacy-of-using-a-novel-low-volume-bone-marrow-aspiration-technique-to-treat-knee-osteoarthritis-a-retrospective-cohort-study
#39
JOURNAL ARTICLE
Daniel Kuebler, Alexandra Schnee, Lisa Moore, Jason Kouri, Alexis McLaughlin, Robert Hanson, Patrick Kuebler, Ignacio Dallo, Alberto Gobbi
BACKGROUND: Intra-articular bone marrow concentrate (BMC) and aspirate (BMA) injections have been used with mixed results to treat osteoarthritis (OA). Given the various aspiration and concentration methods available for preparing bone marrow, more data are needed to identify the optimal bone marrow harvesting techniques to treat OA. METHODS: This retrospective cohort study examined the effect of using low-volume BMAs harvested using the Marrow Cellution™ (MC) device on 160 patients (262 knees) suffering from pain due to knee OA, KL grades 2-4, that did not respond to conservative treatment...
2022: Stem Cells International
https://read.qxmd.com/read/36431138/orthobiologic-injections-for-the-treatment-of-hip-osteoarthritis-a-systematic-review
#40
REVIEW
Marco Zaffagnini, Angelo Boffa, Luca Andriolo, Federico Raggi, Stefano Zaffagnini, Giuseppe Filardo
The use of orthobiologics is gaining increasing interest as a minimally invasive treatment for hip osteoarthritis (OA). The aim of this study was to investigate the evidence about the safety and efficacy of these products. A systematic review of the literature was performed according to the PRISMA and Cochrane guidelines. The study quality was assessed using the RoB 2.0 for randomized controlled trials (RCTs) and the modified Coleman Methodology Score (mCMS) for all studies. A total of 20 clinical studies (735 patients) was identified, 12 on PRP injections and eight on cell-based therapies (five from bone marrow, two from adipose tissue, and one from amniotic fluid)...
November 10, 2022: Journal of Clinical Medicine
keyword
keyword
67529
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.